Evaluation of the lower extremity blood supply in no-option critical limb ischemia patients with stem cell transplantation by time maximum intensity projection CT perfusion: A single-centre prospective study

Abstract

Objectives

Cell therapy has had satisfactory safety and efficacy outcomes for no-option critical limb ischaemia (NO-CLI) patients. In the current study, we aimed to compare the image quality of ischaemic lower limb blood vessels shown on volumetric CT-based time maximum intensity projection CT perfusion (t-MIP CTP) versus single-phase CTA (sCTA). We also tried to quantify the blood flow of the ischaemic lower extremity based on the t-MIP technique, not only to precisely show the dynamic change in blood flow from before to after cell therapy but also to detect any relationship between this change and patient prognosis.

Methods

A total of 31 patients with thromboangiitis obliterans (TAO)-induced NO-CLI who had been referred from the department of vascular surgery to undergo autologous stem cell transplantation into a single limb from January 2020 to March 2021 were prospectively enrolled in this study. Preoperative sCTA or t-MIP CTP and postoperative 1-month t-MIP CTP were performed in all patients. Clinical outcomes, including the 1-month ankle-brachial index (ABI) and 3-month CLI status, were also analysed. Image quality, including objective scores (attenuation, signal-to-noise ratio [SNR] and contrast-to-noise ratio [CNR]), subjective scores and collateral scores, was compared between preoperative sCTA and t-MIP CTP. Vascular volume was calculated as the total volume (mL) of lower limb arteries within the scanning range. All images and calculations were performed by 2 separate radiologists. Receiver operating characteristic curves were drawn to reveal the sensitivity and specificity of vascular volume and ABI in predicting prognosis.

Results

Both sCTA and t-MIP CTP images exhibited good quality for diagnosis. t-MIP CTP images showed significantly higher attenuation, SNR and CNR in all arterial segments (popliteal artery, anterior tibial artery, posterior tibial artery and peroneal artery). In subjective and collateral score evaluations, t-MIP CTP images were also significantly better than sCTA images (both p < .05). At 1 month after transplantation, both vascular volume and ABI showed significant improvement (both p < .01). At 3 months after transplantation, 38.71% of patients (12/31) achieved CLI relief (Rutherford class < 4). Through the receiver operating characteristic (ROC) curve, the 1-month vascular volume increase ratio showed better ability to predict the 3-month prognosis (radiologist 1: AUC, 0.757; sensitivity, 0.750; specificity, 0.840; radiologist 2: AUC, 0.803; sensitivity, 0.500; specificity, 1.000) than the 1-month ABI increase ratio (AUC, 0.607; sensitivity, 0.230; specificity, 0.820) or 1-month ABI (AUC, 0.410; sensitivity, 0.080; specificity, 0.580).

Conclusion

t-MIP CTP showed significantly higher-quality images of ischaemic limb vascularity than sCTA. t-MIP CTP can reveal the anatomical information of collaterals more accurately, which is of great importance for NO-CLI patients undergoing cell transplantation. The 1-month vascular volume increase ratio can predict the 3-month prognosis more precisely on this basis.

Keywords

critical limb ischaemia computed tomography cell therapy

Get full access to this article

View all access options for this article.

References

Levin

Arinze

Siracuse

. Lower extremity critical limb ischemia: a review of clinical features and management. Trends Cardiovasc Med 2019; 17: 10–15.

Hassanshahi

Khabbazi

Peymanfar

, et al. Critical limb ischemia: current and novel therapeutic strategies. J Cell Physiol 2019; 234: 14445–14459.

Norgren

Hiatt

Dormandy

, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007; 45(suppl S): S5–S67.

Ryu

Kim

, et al. Comparison of clinical outcome of infrapopliteal angioplasty between Korean diabetic and non- diabetic patients with critical limb ischemia. Circ J 2012; 76: 335–341.

Kum

Tan

Schreve

, et al. Midterm outcomes from a pilot study of percutaneous deep vein arterialization for the treatment of no- option critical limb ischemia. J Endovasc Ther 2017; 24: 619–626.

Hao

Tianyue

Yuan

, et al. Three-year outcomes of peripheral blood mononuclear cells vs purified CD34 cells in the treatment of angiitis-induced no-option critical limb ischemia and a cost-effectiveness assessment: a randomized single-blinded noninferiority trial. Stem Cells Transl Med 2021; 10: 647–659.

Hao

Tianyue

Yifan

, et al. The peripheral blood mononuclear cells versus purified CD34 cells transplantation in patients with angiitis-induced critical limb ischemia trial: 5-year outcomes and return to work analysis-a randomized single-blinded non-inferiority trial. Stem Cell Res Ther 2022; 13: 116.

Losordo

Kibbe

Mendelsohn

, et al. A randomized, controlled pilot study of autologous CD341 cell therapy for critical limb ischemia. Circ Cardiovasc Interv 2012; 5: 821–830.

Kawamoto

Katayama

Handa

, et al. Intramuscular transplantation of G-CSF- mobilized CD34(1) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial. STEM CELLS 2009; 27: 2857–2864.

10.

Zhihui

Bin

Weiguo

, et al. Transplantation of purified CD341 cells in the treatment of critical limb ischemia. J Vasc Surg 2013; 58: 404–411.

11.

Murayama

Suzuki

Matsukiyo

, et al. Preliminary study of time maximum intensity projection computed tomography imaging for the detection of early ischemic change in patient with acute ischemic stroke. Medicine (Baltim) 2018; 97: e9906.

12.

Cao

Jiang

, et al. Evaluation of intracranial vascular status in patients with acute ischemic stroke by time maximum intensity projection CT angiography: a preliminary study. Acad Radiol 2020; 27: 696–703.

13.

Dawson

. Functional imaging in CT. Eur J Radiol 2006; 60: 331–340.

14.

Hur

Jae

Jang

, et al. Quantitative assessment of foot blood flow by using dynamic volume perfusion CT technique: a feasibility study. Radiology 2016; 279: 195–206.

15.

Chao

. A new general maximum intensity projection technology via the hybrid of U-net and radial basis function neural network. J Digit Imaging 2021; 34: 1264–1278.

16.

Olin

. Thromboangiitis obliterans (Buerger’s disease). N Engl J Med 2000; 343: 864–868.

17.

Shionoya

. Diagnostic criteria of Buerger’s disease. Int J Cardiol 1998; 66: S243–S245.

18.

Dong

Pan

Fang

, et al. Purified CD34 cells versus peripheral blood mononuclear cells in the treatment of angiitis-induced no-option critical limb ischaemia: 12-Month results of a prospective randomised single-blinded non-inferiority trial. EBioMedicine 2018; 35: 46–57.

19.

Graziani

Silvestro

Bertone

, et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg 2007; 33: 453–460.

20.

Wrixon

. New ICRP recommendations. J Radiol Prot 2008; 28: 161–168.

21.

Sahoo

Klychko

Thorne

, et al. Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity. Circ Res 2011; 109: 724–728.

22.

Kawamoto

Iwasaki

Kusano

, et al. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation 2006; 114: 2163–2169.

23.

Pan

Liu

Fang

, et al. Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia. Stem Cell Res Ther 2019; 10: 15.

24.

Nativel

Potier

Alexandre

, et al. Lower extremity arterial disease in patients with diabetes: a contemporary narrative review. Cardiovasc Diabetol 2018; 17: 138.

25.

Davies

Kenkre

Williams

. Current utility of the ankle–brachial index (ABI) in general practice: implications for its use in cardiovascular disease screening. BMC Fam Pract 2014; 15: 69.